Philips: FDA approves Onvision
(CercleFinance.com) - Philips and B.
Braun announce that they have received 510(k) clearance from the US FDA for Onvision, a breakthrough ultrasound guidance solution for real-time needle tip tracking.
Available exclusively on the latest version of their Xperius ultrasound system with the dedicated Stimuplex Onvision needle, Onvision gives anesthesiologists the confidence to accurately position the needle tip inside the body for Peripheral Nerve Blocks (PNBs).
In addition to FDA approval, the Onvision solution is CE marked. It is available for sale in the European Union and Chile and is set to be available in the US in the fourth quarter of 2020.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
Braun announce that they have received 510(k) clearance from the US FDA for Onvision, a breakthrough ultrasound guidance solution for real-time needle tip tracking.
Available exclusively on the latest version of their Xperius ultrasound system with the dedicated Stimuplex Onvision needle, Onvision gives anesthesiologists the confidence to accurately position the needle tip inside the body for Peripheral Nerve Blocks (PNBs).
In addition to FDA approval, the Onvision solution is CE marked. It is available for sale in the European Union and Chile and is set to be available in the US in the fourth quarter of 2020.
Copyright (c) 2020 CercleFinance.com. All rights reserved.